INTRODUCTION

RESULTS
Discovery GWAS for GSD in an admixed Chilean population
The Discovery GWAS stage involved 1,235 admixed Chileans Latinos with Mapuche Native American Ancestry genotyped using the Affymetrix Axiom® Genome-Wide LAT 1
World Array 4 (figure S1). After genotype calling and quality controls, 1,095 individuals (529 GSD cases and 566 controls) and 677,835 SNPs remained for analysis (table 1) . We imputed genotypes in these individuals using the 1000 Genomes Project Phase 3 reference panel 21 and achieved a total number of 9,433,911 SNPs and Indels. We tested for genetic association with GSD by performing a logistic regression analysis adjusted by age (cases=51.32±10.67, controls=49.87±9.57, one-way ANOVA P=0.018), since other known associated covariates such as sex (cases=92.43%, controls=92.57%, Z score test P=0.928), BMI (cases=29.44±4.28, controls=29.66±3.94, one-way ANOVA P=0.376) and ancestry composition (cases=46.3%±7.0%, controls=45.5%±7.5%, one-way ANOVA P=0.069), did not differ significantly between cases and controls.
Genome-wide association results are presented in the figure 1 and consider a genomic control inflation factor λ =1.02 ( figure S2 ). While we did not detect genome-wide significant associations, several suggestive signals (P<1x10 -5 ) were observed. Top-ten candidate variants with suggestive association with GSD were found within ELMO1 (rs4446645, P=3.36x10 -7 ), 5q34 locus (rs10463138, P=2.47x10 -6 ), 4q12 locus (rs74537816, P=3.54x10 -6 ), TRAF3 (rs368550004, P=3.92x10 -6 ), 9p21.1 locus (rs4879592, P=4.66x10 -6 ), (rs10918361, P=4.91x10 -6 ), 3p22.2 locus (rs73827633, P=5.06x10 -6 ), ABCG8
OLFML2B
(rs11887534, P=5.24x10 -6 ), 11p15.3 locus (rs147367002, P=7.63x10 -6 ) and TRPV1 (rs7223530, P=8.07x10 -6 ) (table 2) . Aside from ABCG8, none of the GWAS signals associated with GSD reported in a recent large meta-analysis of individuals with European ancestry 10 reached suggestive genome-wide significance (table S1) . 
Replication Analyses for ABCG8 and TRAF3 variants in Europeans cohorts
We originally identified ABCG8 as a risk factor for GSD in a German population from Immunohistochemical staining in the gallbladder mucosa revealed that TRAF3 protein was observed in different gallbladder cell types such as the epithelium, smooth muscle fibers, arterioles and veins ( figure 4A ). Notably, we found a significant decrease in TRAF3 protein levels in the duodenal mucosa of GSD cases compared to control individuals (P<0.001, two-tailed t-test; figure 4B and 4C) and also a significant decrease of TRAF3 transcripts in a set of 41 RNA samples from duodenal (19 cases, 22 controls, P<0.001, two-tailed t-test) and gallbladder mucosa (11 cases and 11 controls, P=0.015, two-tailed t-test) ( figure 4D ).
These results show significant lower levels of TRAF3 in GSD affected individuals, suggesting a functional contribution of this gene during the inflammatory response observed during the onset or development of the disease.
DISCUSSION
Herein we report that common genetic variation in ABCG8 and TRAF3 genes confer risk to GSD and GBC in the admixed Chilean population. The signal replicated for the ABCG8 gene has been reported in several world populations including Latinos. 10 In the Discovery stage, the leading SNP rs11887534 (D19H) showed a lower magnitude of association, compared with the estimated from the German population, 11 and this could be explained by the difference in the risk allele frequency (C allele) that is higher in Chilean controls (0.079 vs. 0.05, respectively). This difference is also reflected in the effect size, where a lower OR in Chile (OR = 1.88, CI 95% = 1.43-2.47) is observed compared with Germany (OR = 2.00, CI 95% 1.61-2.50). This could be a reason for not being able to detect in the discovery stage a genome-wide signal (p < 5x10 -8 ) in the ABCG8 locus, suggesting that larger sample sizes are required to reach that significance level in future studies on this population.
The OR obtained for ABCG8 in the discovery stage represents a PAR of 8.7%, while for the TRAF3 signal (rs12882491, risk allele C) the OR of 1.5 (CI 95% = 1.26-1.78)
represents a PAR of 24.2%, indicating that TRAF3 has a higher genetic contribution than ABCG8 in this cohort. Taking together, the combined effect of both associations gives an estimated PAR of 30.79%, meaning that if their contribution for the disease is hypothetically eliminated 31 , there would be 30.79% fewer affected individuals in the population. In addition, SNP x SNP epistasis analysis showed non-significant interaction between ABCG8 and TRAF3 association signals (p = 0.399), suggesting that the genetic contribution of both risk factors is independent from each other. While the association ABCG8 variant was consistently observed in all the populations in this study, TRAF3
association is only present in Chilean samples, indicating an ethnic-specific effect. This needs to be further validated in other closely related Latino populations from Peru, Argentina and Bolivia that also have a high GSD prevalence.
32-34
Here we also observed that ABCG8 and TRAF3 variants are significantly associated with GBC in admixed Chileans. The ABCG8 rs11887534 variant has been previously associated with this malignancy in China 25 , India 24 and European populations 35 and most of the studies show that the GBC risk is more pronounced in patients that also had biliary stones in the gallbladder, as it is likely observed in this Chilean cohort (i.e. 90% of female GBC patients with cholesterol gallstones). This is the first time that the ABCG8 and TRAF3
genes showed significant association with GBC in an American population and thus TRAF3 represents a novel risk factor for this malignancy. indicates a crosstalk between the formation of cholesterol stones and inflammatory processes that promote the development and progression of the disease and suggests that ABCG8 and TRAF3 could be both relevant actors in GSD pathology. First, it is known that the ABCG8 variant promotes gallstone formation by enhancing the efflux of cholesterolsaturated bile. 12 Second, lower expression levels of TRAF3 in duodenal mucosa and gallbladder epithelium of GSD patients (as described in the present study) could be responsible for increased production of pro-inflammatory factors, such as NF-κB, IL-6 and IL-12B, as well as for decreased activity of anti-inflammatory factors such as type 1 interferon and IL-10. 41 45-47 The latter has already been associated with GSD and GBC development and progression. 48 In addition, a TRAF3 (R118W) mutation that correlates with lower expression levels of the gene, has been associated with higher susceptibility to the development of multiple myelomas and herpes simplex virus encephalitis,stressing that variants controlling TRAF3 mRNA levels may be involved in GSD and GBC etiology.
In summary, our results confirm the association of ABCG8 and identify TRAF3 as a novel candidate gene for GSD and GBC in the high-risk Chilean population. These genes could be functionally involved in the cascade of events that triggers gallstone formation and the inflammatory response observed in affected patients. Our results may help to develop novel therapies and/or prevention strategies for these prevalent diseases. 
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